Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 1182.00 | 823.25 | 1.4358 | 1.7793 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 625.00 | 384.25 | 987.00 | 823.25 | 1.1989 | 1.3588 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 1120.00 | 823.25 | 1.3605 | 1.6463 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 425.00 | 823.25 | 0.5163 | 0.0960 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 625.00 | 384.25 | 908.00 | 823.25 | 1.1029 | 1.1865 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 998.00 | 823.25 | 1.2123 | 1.3827 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 384.25 | 776.00 | 823.25 | 0.9426 | 0.8953 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 625.00 | 384.25 | 515.00 | 823.25 | 0.6256 | 0.3053 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 625.00 | 384.25 | 727.00 | 823.25 | 0.8831 | 0.7861 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 625.00 | 384.25 | 350.00 | 823.25 | 0.4251 | -0.0814 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 846.00 | 823.25 | 1.0276 | 1.0502 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 733.00 | 823.25 | 0.8904 | 0.7995 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 384.25 | 737.00 | 823.25 | 0.8952 | 0.8085 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 673.00 | 823.25 | 0.8175 | 0.6650 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 685.00 | 823.25 | 0.8321 | 0.6920 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 636.00 | 823.25 | 0.7726 | 0.5815 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 796.00 | 823.25 | 0.9669 | 0.9397 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 625.00 | 384.25 | 774.00 | 823.25 | 0.9402 | 0.8909 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 619.00 | 823.25 | 0.7519 | 0.5430 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 384.25 | 272.00 | 823.25 | 0.3304 | -0.2697 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 610.00 | 823.25 | 0.7410 | 0.5226 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 625.00 | 384.25 | 991.00 | 823.25 | 1.2038 | 1.3675 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 770.00 | 823.25 | 0.9353 | 0.8820 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 625.00 | 384.25 | 690.00 | 823.25 | 0.8381 | 0.7032 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 625.00 | 384.25 | 377.00 | 823.25 | 0.4579 | -0.0172 |